GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yixintang Pharmaceutical Group Co Ltd (SZSE:002727) » Definitions » EPS (Basic)

Yixintang Pharmaceutical Group Co (SZSE:002727) EPS (Basic) : ¥0.92 (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Yixintang Pharmaceutical Group Co EPS (Basic)?

Yixintang Pharmaceutical Group Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was ¥0.41. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.92.

Yixintang Pharmaceutical Group Co's EPS (Diluted) for the three months ended in Mar. 2024 was ¥0.41. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.92.

Yixintang Pharmaceutical Group Co's EPS without NRI for the three months ended in Mar. 2024 was ¥0.48. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 1.21.

During the past 12 months, Yixintang Pharmaceutical Group Co's average EPS without NRIGrowth Rate was -45.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was -2.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 9.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Yixintang Pharmaceutical Group Co's highest 3-Year average EPS without NRI Growth Rate was 32.60% per year. The lowest was -2.20% per year. And the median was 17.10% per year.


Yixintang Pharmaceutical Group Co EPS (Basic) Historical Data

The historical data trend for Yixintang Pharmaceutical Group Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yixintang Pharmaceutical Group Co EPS (Basic) Chart

Yixintang Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.06 1.38 1.56 1.70 0.92

Yixintang Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.45 0.31 -0.23 0.41

Yixintang Pharmaceutical Group Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Yixintang Pharmaceutical Group Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(549.442-0)/596.765
=0.92

Yixintang Pharmaceutical Group Co's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(241.918-0)/596.005
=0.41

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yixintang Pharmaceutical Group Co  (SZSE:002727) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Yixintang Pharmaceutical Group Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Yixintang Pharmaceutical Group Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Yixintang Pharmaceutical Group Co (SZSE:002727) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Hongxiang Road, Economic Development Zone, Yunnan province, Kunming City, CHN, 650500
Yixintang Pharmaceutical Group Co Ltd is a China-based company engages in the operation of pharmaceutical retail chains and wholesale businesses. Its products include traditional Chinese medicine, Western medicine, and medical equipment.
Executives
Zhang Yong Directors, executives
Xiao Dong Lei Executives
Liu Qiong Director
Ruan Hong Xian Directors, executives
Guo Chun Li Director
Ruan Guo Wei Directors, executives
Li Zheng Hong Directors, executives
Zhao Biao Directors, executives
Tian Jun Directors, Directors, and Executives
Xu Ke Yi Director
Luo Yong Bin Executives
Zhou Hong Yun Directors, executives

Yixintang Pharmaceutical Group Co (SZSE:002727) Headlines

No Headlines